Event Details

On-Demand TSANZ Position Paper Webinar: Treatment of Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. 

Register now to watch a summary of the TSANZ position paper on the Treatment of Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. To view the paper click here Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision - Mackintosh - 2024 - Respirology - Wiley Online Library

Webinar Topic:

 The session will cover both pharmacological and non-pharmacological aspects of managing IPF and PPF. 

Chairs: Dr. Gregory Keir and Professor Tamera Corte 

Speaker

•  Dr. John Mackintosh - The Prince Charles Hospital

John is a clinician researcher in the field of respiratory and lung transplant medicine, and currently practices as a consultant respiratory physician at The Prince Charles Hospital, Brisbane. John has a particular interest in interstitial lung disease having completed a clinical fellowship in interstitial lung disease in 2018 at The Royal Brompton Hospital, London. John provides a dedicated interstitial lung disease outpatient service and is co-chair of the Queensland Statewide Interstitial Lung Disease Multi-Disciplinary Meeting that provides diagnostic and management advice to physicians across Australia. He has a number of active research studies funded through the NHMRC and MRFF and is principal investigator of multiple phase 1 to 3 clinical trials in ILD.John is a clinician researcher in the field of respiratory and lung transplant medicine, and currently practices as a consultant respiratory physician at The Prince Charles Hospital, Brisbane. John has a particular interest in interstitial lung disease having completed a clinical fellowship in interstitial lung disease in 2018 at The Royal Brompton Hospital, London. John provides a dedicated interstitial lung disease outpatient service and is co-chair of the Queensland Statewide Interstitial Lung Disease Multi-Disciplinary Meeting that provides diagnostic and management advice to physicians across Australia. He has a number of active research studies funded through the NHMRC and MRFF and is principal investigator of multiple phase 1 to 3 clinical trials in ILD.